Prognostic factors in cancer of unknown primary site

被引：2

作者：

Munoz, Alberto ^{[1
]}

Fuente, Natalia ^{[1
]}

Rubio, Itziar ^{[1
]}

Ferreiro, Josefa ^{[1
]}

Martinez-Bueno, Alejandro ^{[1
]}

Lopez-Vivanco, Guillermo ^{[1
]}

机构：

[1] Osakidetza SVS, Hosp Cruces, Dept Med Oncol, Bizkaia 48903, Spain

来源：

CLINICAL & TRANSLATIONAL ONCOLOGY | 2008年 / 10卷 / 01期

关键词：

D O I：

10.1007/s12094-008-0156-2

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：64 / 65

页数：2

共 7 条

[1] Development and validation of a prognostic model to predict the length of survival in patients with carcinomas of an unknown primary site [J].

Culine, S ;

Kramar, A ;

Saghatchian, M ;

Bugat, R ;

Lesimple, T ;

Lortholary, A ;

Merrouche, Y ;

Laplanche, A ;

Fizazi, K .

JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (24) :4679-4683

[2] Carcinoma of unknown primary site: Treatment with 1-hour paclitaxel, carboplatin, and extended-schedule etoposide [J].

Hainsworth, JD ;

Erland, JB ;

Kalman, LA ;

Schreeder, MT ;

Greco, FA .

JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (06) :2385-2393

[3] Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer [J].

Hurwitz, H ;

Fehrenbacher, L ;

Novotny, W ;

Cartwright, T ;

Hainsworth, J ;

Heim, W ;

Berlin, J ;

Baron, A ;

Griffing, S ;

Holmgren, E ;

Ferrara, N ;

Fyfe, G ;

Rogers, B ;

Ross, R ;

Kabbinavar, F .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (23) :2335-2342

[4]

Kabbinavar F, 2006, J CLIN ONCOL, V24, p155S

[5] Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer:: results of a multivariate analysis of 3825 patients [J].

Köhne, CH ;

Cunningham, D ;

Di Costanzo, F ;

Glimelius, B ;

Blijham, G ;

Aranda, E ;

Scheithauer, W ;

Rougier, P ;

Palmer, M ;

Wils, J ;

Baron, B ;

Pignatti, F ;

Schöffski, P ;

Micheel, S ;

Hecker, H .

ANNALS OF ONCOLOGY, 2002, 13 (02) :308-317

[6] Prognostic and predictive factors of patients with cancer of unknown origin treated with a paclitaxel-based chemotherapy [J].

Muñoz, A ;

Fuente, N ;

Barceló, R ;

Rubio, I ;

Ferreiro, J ;

Vivanco, GL .

MEDICINA CLINICA, 2004, 122 (06) :216-218

[7] Carcinoma of unknown primary site:: development in a single institution of a prognostic model based on clinical and serum variables [J].

Ponce Lorenzo, J. ;

Segura Huerta, A. ;

Diaz Beveridge, R. ;

Gimenez Ortiz, A. ;

Aparisi Aparisi, F. ;

Fleitas Kanonnikoff, T. ;

Richart Aznar, P. ;

de la Cueva Sapina, H. ;

Montalar Salcedo, J. .

CLINICAL & TRANSLATIONAL ONCOLOGY, 2007, 9 (07) :452-458

← 1 →